We are live on ! Find out more
CANO

Cano Health, Inc.

Delisted

CANO was delisted on the 2nd of February, 2024.

163 hedge funds and large institutions have $122M invested in Cano Health, Inc. in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 58 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,034% more call options, than puts

Call options by funds: $6.07M | Put options by funds: $535K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less funds holding

Funds holding: 186163 (-23)

19% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 58

23% less capital invested

Capital invested by funds: $157M → $122M (-$35.5M)

58% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 38

Holders
163
Holders Change
-23
Holders Change %
-12.37%
% of All Funds
2.6%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
47
Reduced
58
Closed
38
Calls
$6.07M
Puts
$535K
Net Calls
+$5.53M
Net Calls Change
-$3.74M
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$610K +$59.6K +439 +7%
IAM
27
Innovis Asset Management
Illinois
$584K +$198K +1,462 +30%
Tudor Investment Corp
28
Tudor Investment Corp
Connecticut
$557K
Barclays
29
Barclays
United Kingdom
$555K +$731K +5,384 +748%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$497K -$9.37K -69 -1%
Ameriprise
31
Ameriprise
Minnesota
$466K +$197K +1,448 +39%
Goldman Sachs
32
Goldman Sachs
New York
$451K -$745K -5,485 -53%
OCM
33
Ovata Capital Management
Hong Kong
$362K +$493K +3,630 +1,037%
WMSA
34
Weiss Multi-Strategy Advisers
New York
$353K +$358K +2,634 +211%
Swiss National Bank
35
Swiss National Bank
Switzerland
$336K -$30.5K -225 -6%
AllianceBernstein
36
AllianceBernstein
Tennessee
$335K +$102K +751 +26%
Hudson Bay Capital Management
37
Hudson Bay Capital Management
Connecticut
$319K -$930K -6,849 -66%
GCP
38
GSA Capital Partners
United Kingdom
$294K +$407K +2,995 +1,274%
Invesco
39
Invesco
Georgia
$283K +$328K +2,416 +346%
BCM
40
BCK Capital Management
Connecticut
$270K -$254K -1,873 -39%
AC
41
Addison Capital
Pennsylvania
$268K -$244K -1,797 -38%
Bank of America
42
Bank of America
North Carolina
$230K +$59.1K +435 +21%
Wells Fargo
43
Wells Fargo
California
$219K +$41.9K +309 +15%
Man Group
44
Man Group
United Kingdom
$217K
First Trust Advisors
45
First Trust Advisors
Illinois
$197K -$299K -2,201 -50%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$191K +$6.38K +47 +2%
JAIC
47
Josh Arnold Investment Consultant
Minnesota
$191K +$176K +1,300 +162%
Parallax Volatility Advisers
48
Parallax Volatility Advisers
California
$183K +$76K +560 +39%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$182K +$8.01K +59 +3%
UBS AM
50
UBS AM
Illinois
$180K

CANO Hedge Fund Activity: Q1 2023 in Review

163 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. (CANO) for Q1 2023, worth a combined $122M — down 23% from $157M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of CANO and 16 opened new positions — a net loss of 22 holders — while 58 trimmed existing stakes and 47 added.

The largest buyer was Diameter Capital Partners, opening a new position worth an estimated $29.4M. The largest seller was Morgan Stanley, cutting an estimated $5.72M.

  • 163 institutional investors held Cano Health, Inc. (CANO) as of Q1 2023, down from 186 in Q4 2022.
  • Funds reported $122M of Cano Health, Inc. stock for Q1 2023, down 23% quarter-over-quarter.
  • 16 funds opened new Cano Health, Inc. positions in Q1 2023 and 38 closed out, a net change of -22 holders.
  • The largest Cano Health, Inc. buyer in Q1 2023 was Diameter Capital Partners, an estimated $29.4M added.
  • The largest Cano Health, Inc. seller in Q1 2023 was Morgan Stanley, an estimated $5.72M sold.

Based on aggregated 13F filings for Q1 2023.